Ironwood Pharmaceuticals | IRWD - Ordinary Share Capital



Ironwood Pharmaceuticals reported $160K in Ordinary Share Capital for its fiscal quarter ending in December of 2024.


Ordinary Share Capital Change Date
Acadia Pharmaceuticals USD 167.36M 167.35M Jun/2025
Agios Pharmaceuticals USD 58.04M 57.96M Jun/2025
Almirall EUR 214.79M 189.17M Jun/2025
Alnylam Pharmaceuticals USD 130.98M 129.67M Jun/2025
Amarin USD 308.15M 2.85M Mar/2025
Ardelyx USD 240.77M 240.74M Jun/2025
Astellas Pharma JPY 1.79B 101.21B Jun/2025
AstraZeneca USD 1.55B 1.16B Jun/2025
Charles River Laboratories USD 49.21M 48.7M Jun/2025
Exact Sciences USD 189.22M 187.33M Jun/2025
Halozyme Therapeutics USD 117.62M 117.5M Jun/2025
Incyte USD 194.12M 193.93M Jun/2025
Ironwood Pharmaceuticals USD 160K 0 Dec/2024
MacroGenics USD 63.21M 62.58M Jun/2025
Moderna USD 389M 388.96M Jun/2025
Myriad Genetics USD 900K 0 Mar/2025
Pacira USD 44.9M 44.85M Jun/2025
PTC Therapeutics USD 79.38M 79.3M Jun/2025
Sarepta Therapeutics USD 97.71M 97.7M Jun/2025
Takeda JPY 1.56B 1.69T Jun/2025
Ultragenyx Pharmaceutical USD 96.35M 2.45M Jun/2025